1339058004: Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing alpha-2 adrenergic receptor agonist (product)\Product containing brimonidine (medicinal product)\Brimonidine- and brinzolamide-containing product\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing alpha-2 adrenergic receptor agonist (product)\Product containing brimonidine (medicinal product)\Brimonidine- and brinzolamide-containing product\Product containing only brimonidine and brinzolamide (medicinal product)\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing alpha-2 adrenergic receptor agonist (product)\Product containing brimonidine (medicinal product)\Product containing brimonidine in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing carbonic anhydrase inhibitor (product)\Product containing brinzolamide (medicinal product)\Brimonidine- and brinzolamide-containing product\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing carbonic anhydrase inhibitor (product)\Product containing brinzolamide (medicinal product)\Brimonidine- and brinzolamide-containing product\Product containing only brimonidine and brinzolamide (medicinal product)\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing carbonic anhydrase inhibitor (product)\Product containing brinzolamide (medicinal product)\Product containing brinzolamide in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing imidazole (product)\Product containing brimonidine (medicinal product)\Brimonidine- and brinzolamide-containing product\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing imidazole (product)\Product containing brimonidine (medicinal product)\Brimonidine- and brinzolamide-containing product\Product containing only brimonidine and brinzolamide (medicinal product)\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing azole (product)\Product containing imidazole (product)\Product containing brimonidine (medicinal product)\Product containing brimonidine in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by structure\Product containing brinzolamide (medicinal product)\Brimonidine- and brinzolamide-containing product\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by structure\Product containing brinzolamide (medicinal product)\Brimonidine- and brinzolamide-containing product\Product containing only brimonidine and brinzolamide (medicinal product)\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Medicinal product categorized by structure\Product containing brinzolamide (medicinal product)\Product containing brinzolamide in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension

\Product manufactured as ocular dose form (product)\Product containing brinzolamide in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Product manufactured as ocular dose form (product)\Product containing brimonidine in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension

\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Product containing alpha-2 adrenergic receptor agonist (product)\Product containing brimonidine (medicinal product)\...

\Brimonidine- and brinzolamide-containing product\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension
\Brimonidine- and brinzolamide-containing product\Product containing only brimonidine and brinzolamide (medicinal product)\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension

\Product containing brimonidine in ocular dose form (medicinal product form)\Brimonidine- and brinzolamide-containing product in ocular dose form\Brimonidine and brinzolamide only product in ocular dose form\Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5370560011 Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

5370561010 Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	Plays role	Antiglaucoma therapeutic role	false	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Brinzolamide (substance)	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Brinzolamide (substance)	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	2
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	Is a	Brimonidine and brinzolamide only product in ocular dose form	true	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	Has manufactured dose form	Eye drops suspension	true	Inferred relationship	Some
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Brimonidine tartrate (substance)	true	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Brimonidine tartrate (substance)	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5370560011	Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
5370561010	Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core